fda-Approved Treatment

An FDA-Approved Treatment for Depression That Hasn’t Improved With Medication

Spravato® (Esketamine) — Where Hope Begins to Heal

What Is Spravato®?

Spravato® is an FDA-approved nasal esketamine treatment for adults with treatment-resistant depression or major depression with suicidal ideation.
It is administered only in-office under direct supervision to ensure safety and effectiveness.

Who Qualifies?

Spravato® may be right for you if you have tried two or more oral antidepressants without adequate relief.

How Spravato® Works

Unlike traditional antidepressants, Spravato® targets the N-methyl-D-aspartate (NMDA) receptor, helping to restore synaptic connections in brain cells.

What to Expect During a Session

\

In-Office Administration

You will self-administer the nasal spray under the supervision of a healthcare provider.

\

Observation Period

You’ll relax in a comfortable recliner for at least 2 hours while we monitor your vitals.

\

Ride Home

You cannot drive until the next day, so you will need to arrange a ride home.

Treatment Phases

Phase 1: Induction

Weeks 1-4: Twice a week treatment to jumpstart relief.

Phase 2: Maintenance

Weeks 5-8: Once a week to stabilize mood.

Phase 3: Ongoing

Week 9+: Every 1 or 2 weeks as determined by your provider.

Patient Stories

{
“After years of trying different medications without success, Spravato finally gave me the clarity I was looking for. The team at ACC made me feel safe throughout the entire process.”
— Verified Patient (hipaa Compliant)

Side Effects & Safety

Common side effects are temporary and typically occur during the treatment session:

• Dissociation (feeling disconnected)
• Dizziness or Nausea
• Sedation
• Increased blood pressure (monitored)

Contraindications

Spravato® may not be suitable if you have:

• History of aneurysmal vascular disease
• Arteriovenous malformation
• History of intracerebral hemorrhage
• Uncontrolled hypertension

Expected Benefits

Rapid reduction in depressive symptoms

Improved mood stability

Decreased suicidal ideation

Enhanced overall quality of life

Cost, Insurance & Financing

We believe financial constraints shouldn’t stand in the way of mental health. We work with major insurers and offer financing options.

Cherry Financing

Flexible payment plans.

CareCredit

Health & wellness credit card.

Insurance Check

See if you are covered.

Why Choose ACC?

At Assertive Comprehensive Care, we are dedicated to providing cutting-edge mental health treatments in a compassionate, supportive environment.

Our team consists of board-certified psychiatrists and trained medical professionals who specialize in treatment-resistant depression.

500+ Patients Treated / Expert: Medical Supervision

u

Frequently Asked Questions

What is Spravato®?
Spravato® is an FDA-approved intranasal medication (esketamine) used for adults with Treatment-Resistant Depression (TRD) or Major Depressive Disorder with Acute Suicidal Ideation or Behavior. It works differently from traditional antidepressants by targeting glutamate and enhancing neuroplasticity—helping the brain form healthier connections.
Who is Spravato® for?
Spravato® may be appropriate for adults who:
• Have tried at least two antidepressants without significant improvement
• Experience persistent depressive symptoms
• Struggle with severe or overwhelming depressive episodes
• Need rapid relief while staying safe and supported
How is Spravato® administered?
Treatments are done in-office only, in a private and monitored space.
You self-administer the nasal spray under the direct supervision of an ACC clinician. You remain on-site for 2 hours for monitoring, comfort, and safety.

North Miami Office

Address

12550 Biscayne Blvd, Suite 507,
North Miami, FL 33181

Tel: (305) 204-1209 - Fax: (305) 402-0959

Hours of Operation:

9:00 AM – 6:00 PM

Pembroke Pines Office

Address

650 NW 180th Ter, Suite 101,
Pembroke Pines, FL 33029

Tel: (305) 204-1209 - Fax: (305) 402-0959

Hours of Operation:

8:30 AM – 5:30 PM